Charter Oak Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$3K 707
2022
Q2
$3K Hold
200
﹤0.01% 799
2022
Q1
$3K Hold
200
﹤0.01% 845
2021
Q4
$5K Hold
200
﹤0.01% 703
2021
Q3
$6K Hold
200
﹤0.01% 646
2021
Q2
$8K Hold
200
﹤0.01% 609
2021
Q1
$6K Hold
200
﹤0.01% 613
2020
Q4
$8K Buy
+200
New +$8.33K ﹤0.01% 544

Other funds holding REPL

Charter Oak Capital Management's REPL Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Replimune Group (REPL) in Q3 2022, closing a stake of 200 shares — an estimated $3K sold.

Charter Oak Capital Management first reported a position in REPL in Q4 2020 and held it in 7 quarters. The position peaked at $8K in Q2 2021. 106 funds tracked by Wall St. Rank hold REPL as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Replimune Group position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 200 Replimune Group shares in Q3 2022, an estimated $3K.
  • Charter Oak Capital Management first reported a position in Replimune Group in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's Replimune Group position peaked at $8K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held Replimune Group as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.